Kleintjens, J., Li, X., Simoens, S., Thijs, V., Goethals, M., Rietzschel, E. R., . . . De Ruyck, M. (2013). Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting. Springer International Publishing.
Citação norma ChicagoKleintjens, Joris, et al. Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting. Springer International Publishing, 2013.
MLA引文Kleintjens, Joris, et al. Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting. Springer International Publishing, 2013.
警告：這些引文格式不一定是100％准確.